Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. Collegium Pharmaceutical, Inc. -
Case Number:
1:17-cv-11814
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 16, 2018
Purdue's 'Duplicative' Suit Over OxyContin Generic Gets Ax
Tweaks to a generic opioid's labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston court hearing Tuesday.
-
December 13, 2017
Purdue Loses Bid To Fuse Jumble Of OxyContin Patent Suits
Purdue Pharma LP lost an attempt on Wednesday to squeeze several oxycodone-related patent lawsuits into one trial in Massachusetts federal court, a minor setback in the manufacturer's claims seeking to guard the legal underpinnings of painkiller OxyContin.